G01N 2800/285
Demyelinating diseases
Official title: Demyelinating diseases; Multipel sclerosis
G01N2800/285 (Demyelinating diseases) appears on 273 US grants and 561 published applications in this corpus.
Search patents in G01N- Granted patents
- 273
- Published applications
- 561
- Assignees
- 327
- Inventors
- 1,071
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 5 | 0 |
| 2000 | 4 | 0 |
| 2001 | 5 | 0 |
| 2002 | 2 | 3 |
| 2003 | 1 | 6 |
| 2004 | 3 | 7 |
| 2005 | 4 | 16 |
| 2006 | 4 | 12 |
| 2007 | 4 | 11 |
| 2008 | 3 | 18 |
| 2009 | 7 | 19 |
| 2010 | 8 | 38 |
| 2011 | 10 | 28 |
| 2012 | 15 | 24 |
| 2013 | 16 | 32 |
| 2014 | 12 | 33 |
| 2015 | 14 | 36 |
| 2016 | 12 | 39 |
| 2017 | 16 | 32 |
| 2018 | 17 | 27 |
| 2019 | 15 | 22 |
| 2020 | 21 | 28 |
| 2021 | 13 | 27 |
| 2022 | 14 | 30 |
| 2023 | 7 | 15 |
| 2024 | 15 | 26 |
| 2025 | 12 | 25 |
| 2026 | 3 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for monitoring autoimmune disease8 Sep 2026US 12,730,106 B2The Regents of the University of Micigan
- DNA-replication associated (Rep) protein antibody27 Jan 2026US 12,534,523 B2Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
- Detection of fumarate-derived modification in a test sample27 Jan 2026US 12,535,487 B2University of South Carolina
- Biomarkers for predicting multiple sclerosis disease activity18 Nov 2025US 12,474,336 B2Octave Bioscience, 1nc.
- Biomarkers for multiple sclerosis4 Nov 2025US 12,461,098 B2GLX Analytix ApS
- Antibody based reagents that specifically recognize neurodegenerative disease related forms of the protein tdp-439 Jul 2026US 2026/0194540 A1Arizona Board of Regents on behalf of Arizona State University
- Clinical application of sbcma in cerebrospinal fluid in diagnosis and monitoring of central nervous system autoimmune diseases25 Jun 2026US 2026/0177550 A1Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Biomarkers for multiple sclerosis4 Jun 2026US 2026/0153508 A1GLX Analytix ApS
- Detection of fumarate-derived modification in a test sample14 May 2026US 2026/0133203 A1University of South Carolina
- Structure of fluorescently labeled peptides useful for differentiating multiple sclerosis30 Apr 2026US 2026/0117423 A1HiPep Laboratories
Most cited
By later US patents
- T-cell receptor varible transcripts as disease related markers83US 5,667,967 AThe Board of Trustees of the Leland Stanford Junior University · 1997
- Treatment for multiple sclerosis82US 8,399,514 B2Biogen Idec MA Inc. · 2013
- Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use51US 6,800,287 B2Yeda Research and Development Co. Ltd. · 2004
- Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use48US 7,074,580 B2Yeda Research and Development Co. Ltd. · 2006
- Cerebrospinal fluid protein fragments47US 4,205,057 AThe Government of the United States · 1980